Pharma · Private company
Sun Pharmaceutical Industries Limited
Track this companyFree. Adds Sun Pharmaceutical Industries Limited to your Dealase workspace and tells you when its record changes.
Clinical trials2516 recruiting or active
Pipeline programs41From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline41
- Blue Light Photodynamic Therapy Illuminator device, BLU-U® model 4170EPhase 3 · Actinic KeratosisClinicalTrials.gov · fetched Nov 12, 2026
- CTP-543Phase 3 · Alopecia AreataClinicalTrials.gov · fetched Nov 12, 2026
- DeuruxolitinibPhase 3 · Alopecia AreataClinicalTrials.gov · fetched Nov 12, 2026
- EtanerceptPhase 3 · Moderate-to-severe Chronic Plaque PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- Reformulated Levulan Kerastick containing aminolevulinic acid hydrochloride (ALA HCl), 20%Phase 3 · Actinic KeratosisClinicalTrials.gov · fetched Nov 12, 2026
- TILDPhase 3 · Active Psoriatic ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- TILD sub-cutaneous (SC) injectionPhase 3 · Psoriatic ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- TildrakizumabPhase 3 · Chronic Plaque PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- TildrakizumabPhase 3 · Moderate-to-severe Chronic Plaque PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- Tildrakizumab 100 mgPhase 3 · Moderate to Severe Genital PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 3 · Actinic KeratosisClinicalTrials.gov · fetched Nov 12, 2026
- Vehicle containing excipients only (VEH) without active ingredientPhase 3 · Actinic KeratosisClinicalTrials.gov · fetched Nov 12, 2026
- Abiraterone acetatePhase 2 · Metastatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- ApalutamidePhase 2 · Metastatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- EnzalutamidePhase 2 · Metastatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- GL0034 Dose Level 1Phase 2 · Type II Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- GL0034 Dose Level 2Phase 2 · Type II Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- GL0034 Dose Level 3Phase 2 · Type II Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- GL0034 Dose Level 4Phase 2 · Type II Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- GL0034 Dose Level 5Phase 2 · Type II Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- GL0034 Dose Level 6Phase 2 · Type II Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- SCD-044_Dose 1Phase 2 · Dermatitis, AtopicClinicalTrials.gov · fetched Nov 12, 2026
- SCD-044_Dose 2Phase 2 · Dermatitis, AtopicClinicalTrials.gov · fetched Nov 12, 2026
- SCD-044_Dose 3Phase 2 · Dermatitis, AtopicClinicalTrials.gov · fetched Nov 12, 2026
- SCD-044_High Dose (Dose 3)Phase 2 · Moderate to Severe Plaque PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- SCD-044_Intermediate Dose (Dose 2)Phase 2 · Moderate to Severe Plaque PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- SCD-044_Low Dose (Dose 1)Phase 2 · Moderate to Severe Plaque PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- GL0034Phase 1 · Type II Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- Investigational drugPhase 1 · Actinic Keratosis (AK)ClinicalTrials.gov · fetched Nov 12, 2026
- Ivermectin Cream 1%Phase 1 · RosaceaClinicalTrials.gov · fetched Nov 12, 2026
- Photodynamic therapyPhase 1 · Actinic Keratosis (AK)ClinicalTrials.gov · fetched Nov 12, 2026
- PrRosiver® Cream 1%Phase 1 · RosaceaClinicalTrials.gov · fetched Nov 12, 2026
- RETIN-A MICRO® (Tretinoin) Gel Microsphere, 0.04%Phase 1 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- Soolantra™ Cream 1%Phase 1 · RosaceaClinicalTrials.gov · fetched Nov 12, 2026
- Tapinarof Cream, 1%Phase 1 · Plaque PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- Tretinoin Gel Microsphere, 0.04%Phase 1 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- Vtama® (Tapinarof) Cream, 1%Phase 1 · Plaque PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- Pregnant women exposed to tildrakizumabPregnancy RelatedClinicalTrials.gov · fetched Nov 12, 2026
- Pregnant women not exposed to tildrakizumabPregnancy RelatedClinicalTrials.gov · fetched Nov 12, 2026
- Winlevi (clascoterone) 1% creamAcne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- Winlevi (Clascoterone) cream 1%Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- An Open-Label Pharmacokinetic Study for Patients With Actinic Keratosis on the Upper Extremities or the FacePHASE1 · RECRUITING · started Aug 4, 2026ClinicalTrials.gov NCT07729579 · fetched Nov 12, 2026
- Study to Evaluate if Exposure to Drug is Impacted in Participants With Renal InsufficiencyPHASE1 · RECRUITING · started Feb 25, 2026ClinicalTrials.gov NCT07385547 · fetched Nov 12, 2026
- Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes MellitusPHASE2 · RECRUITING · started Jan 20, 2026ClinicalTrials.gov NCT07282743 · fetched Nov 12, 2026
- A Study Comparing Ivermectin Cream 1%, Soolantra™ Cream 1%, PrROSIVER® Cream1% to Placebo Control in the Treatment of Moderate to Severe Facial Rosacea.PHASE1 · COMPLETED · started Dec 9, 2025ClinicalTrials.gov NCT07795567 · fetched Nov 12, 2026
- Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper ExtremitiesPHASE3 · RECRUITING · started Nov 29, 2025ClinicalTrials.gov NCT07144852 · fetched Nov 12, 2026
- Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and ScalpPHASE3 · RECRUITING · started Nov 19, 2025ClinicalTrials.gov NCT07144345 · fetched Nov 12, 2026
- A Study Comparing Tapinarof Cream 1% and Vtama® Cream 1% in the Treatment of Plaque Psoriasis.PHASE1 · COMPLETED · started Oct 13, 2025ClinicalTrials.gov NCT07546214 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia AreataPHASE3 · RECRUITING · started Aug 5, 2025ClinicalTrials.gov NCT07133308 · fetched Nov 12, 2026
- A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment of Acne VulgarisPHASE1 · COMPLETED · started Aug 4, 2025ClinicalTrials.gov NCT07469228 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Subcutaneous Tildrakizumab in Subjects With Moderate to Severe Genital Psoriasis.PHASE3 · ACTIVE_NOT_RECRUITING · started Mar 21, 2025ClinicalTrials.gov NCT06611163 · fetched Nov 12, 2026
- Efficacy and Safety of Topical Clascoterone (WINLEVI) Cream 1% in Patients With Facial Acneiform RosaceaPHASE2 · RECRUITING · started Mar 14, 2025ClinicalTrials.gov NCT06952517 · fetched Nov 12, 2026
- A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne PatientsPHASE4 · ACTIVE_NOT_RECRUITING · started Jul 1, 2024ClinicalTrials.gov NCT06425900 · fetched Nov 12, 2026
- A Study to Evaluate the Reduction in Sebum (Skin Oil) Induced by Clascoterone Cream 1% in Acne PatientsPHASE4 · COMPLETED · started Feb 14, 2024ClinicalTrials.gov NCT06415279 · fetched Nov 12, 2026
- A Study Evaluating the Efficacy and Safety of Clascoterone Cream 1% in Skin of Color Patients With AcnePHASE4 · COMPLETED · started Sep 1, 2023ClinicalTrials.gov NCT06415305 · fetched Nov 12, 2026
- Psoriatic Immune Response to TildrakizumabPHASE4 · RECRUITING · started Sep 1, 2022ClinicalTrials.gov NCT05390515 · fetched Nov 12, 2026
- Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.PHASE2 · RECRUITING · started Aug 31, 2022ClinicalTrials.gov NCT05422911 · fetched Nov 12, 2026
- Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic ArthritisPHASE3 · ACTIVE_NOT_RECRUITING · started Jun 30, 2022ClinicalTrials.gov NCT04991116 · fetched Nov 12, 2026
- To Assess the Efficacy and Safety of SCD-044 in the Treatment of Moderate to Severe Atopic DermatitisPHASE2 · COMPLETED · started Jul 30, 2021ClinicalTrials.gov NCT04684485 · fetched Nov 12, 2026
- Efficacy and Safety Study of Tildrakizumab in the Treatment of Nail PsoriasisPHASE3 · COMPLETED · started May 13, 2021ClinicalTrials.gov NCT03897075 · fetched Nov 12, 2026
- To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque PsoriasisPHASE2 · COMPLETED · started Mar 25, 2021ClinicalTrials.gov NCT04566666 · fetched Nov 12, 2026
- Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)PHASE3 · COMPLETED · started Jul 1, 2020ClinicalTrials.gov NCT04314544 · fetched Nov 12, 2026
- Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)PHASE3 · ACTIVE_NOT_RECRUITING · started Jul 1, 2020ClinicalTrials.gov NCT04314531 · fetched Nov 12, 2026
- A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque PsoriasisPHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Jan 15, 2020ClinicalTrials.gov NCT03997786 · fetched Nov 12, 2026
- Safety Study for Prospective Assessment of Pregnancy Outcomes in Patients Treated With TildrakizumabRECRUITING · started Aug 29, 2019ClinicalTrials.gov NCT03992729 · fetched Nov 12, 2026
- Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia AreataPHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Apr 4, 2019ClinicalTrials.gov NCT03898479 · fetched Nov 12, 2026